PMID: 6328869Apr 1, 1984

Steric aspects of agonism and antagonism at beta-adrenoceptors: experiments with the enantiomers of terbutaline and pindolol

Acta Pharmacologica Et Toxicologica
A B JeppssonB Waldeck


The enantiomers of terbutaline, a beta 2-selective adrenoceptor agonist, and pindolol, an unselective antagonist with partial agonist activity, were examined with respect to their ability to react in vitro on adrenoceptors in the trachea (mostly beta 2), the soleus muscle (beta 2) and in the papillary muscle of the left ventricle (beta 1) from the guinea-pig (+)-terbutaline was more than 3,000 times less potent than (-)-terbutaline in relaxing the trachea and in depressing subtetanic contractions of the soleus muscle. (+)-terbutaline did not inhibit the effects of (-)-terbutaline in these tissues. The effect of (-)-terbutaline on the papillary muscle was about 200 times weaker than on the soleus. (+)-terbutaline had a negligible inotropic effect on the papillary muscle and it did not inhibit the effect of isoprenaline. The enantiomers of pindolol did not show any consistent agonistic activity under the present experimental conditions. (-)-pindolol inhibited competitively the effect of isoprenaline to the same extent in all three tissues. (+)-pindolol was about 200 times less potent in this respect. Our data do not reveal any qualitative differences in the pharmacological properties between the optical isomers of terbutaline and...Continue Reading


Nov 1, 1972·Journal of Medicinal Chemistry·K Wetterlin
May 1, 1973·British Journal of Pharmacology·R T BrittainR J Marshall
Jun 25, 1966·Nature·R Howe, R G Shanks
Sep 1, 1980·The Journal of Pharmacy and Pharmacology·U Johansson, B Waldeck
Dec 1, 1982·Naunyn-Schmiedeberg's Archives of Pharmacology·H MattssonT Olsson
Jan 1, 1983·General Pharmacology·B J Clark, A Bertholet
Jan 1, 1982·British Journal of Clinical Pharmacology·B J ClarkA Bertholet
Feb 1, 1980·Acta Pharmacologica Et Toxicologica·E Holmberg, B Waldeck
Jun 30, 1908·The Journal of Physiology·A R Cushny


Jan 1, 1989·British Journal of Clinical Pharmacology·L BorgströmJ Paulson
Jul 1, 1985·Clinical and Experimental Pharmacology & Physiology·B Waldeck, E Widmark
Jan 1, 1990·European Journal of Clinical Pharmacology·L BorgströmB Angelin
Apr 7, 2017·Chemical & Pharmaceutical Bulletin·Hitomi UchimotoIkuo Kawasaki
Jan 1, 1995·Pharmacology & Toxicology·B Waldeck
Mar 1, 1990·Pharmacology & Toxicology·L H JohanssonE Rosengren
Jan 24, 2016·European Journal of Drug Metabolism and Pharmacokinetics·Nuggehally R Srinivas
Oct 1, 1985·European Journal of Drug Metabolism and Pharmacokinetics·P W HaleA Poklis
Aug 14, 2020·Journal of Clinical Pharmacology·Paulo Vinicius Bernardes GonçalvesVera Lucia Lanchote
Mar 29, 2002·The Annals of Pharmacotherapy·Majid VakilyDion Brocks

Related Concepts

Cavia porcellus
Myocardial Contraction
Structure of Papillary Muscle
Beta-adrenergic receptor
Molecular Stereochemistry

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.